The Role of Dopamine in Gastric Cancer
Author Information
Author(s): Cimpeanu Radu-Cristian, Fortofoiu Dragoș, Sandu Elena, Dragne Ioana-Gabriela, Caragea Mariana-Emilia, Dumitriu-Stan Roxana-Ioana, Salmen Bianca-Margareta, Boldeanu Lidia, Reurean-Pintilei Delia Viola, Vere Cristin-Constantin
Primary Institution: University of Medicine and Pharmacy of Craiova, Romania
Hypothesis
What is the link between dopamine activity and gastric cancer progression?
Conclusion
Dopamine influences gastric cancer progression through complex interactions with key proteins involved in tumor growth and invasion.
Supporting Evidence
- Dopamine has notable effects on STAT-3 and DARPP-32, which are involved in cancer progression.
- High levels of DARPP-32 and STAT-3 are associated with poor prognosis in gastric cancer.
- Dopamine's role in immune response modulation could complicate cancer progression.
- Targeting the DARPP-32/CXCR4/CXCL-12 axis may provide new therapeutic strategies for gastric cancer.
Takeaway
Dopamine, a brain chemical, also affects stomach cancer by helping cancer cells grow and spread. Understanding this can help create better treatments.
Methodology
A systematic review was conducted using databases like PubMed, Scopus, and Web of Science to analyze studies on dopamine's role in gastric cancer.
Potential Biases
Potential bias in study selection and data extraction due to the subjective nature of qualitative assessments.
Limitations
The study included only a small number of articles focused on human patients, excluding cell culture studies.
Participant Demographics
Human patients with gastric cancer.
Statistical Information
P-Value
p<0.01
Confidence Interval
95%
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website